Atlas Trials

Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Clinical trial NCT04698941 · UNKNOWN

Trial details

NCT number
NCT04698941
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2021-07-25
Primary completion
2021-12-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.